CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | +2.4% | 3,333 | 0.0% | 0.03% | +3.6% |
| Q4 2021 | $41,000 | -24.1% | 3,333 | -4.8% | 0.03% | -28.2% |
| Q3 2021 | $54,000 | +8.0% | 3,500 | 0.0% | 0.04% | +2.6% |
| Q2 2021 | $50,000 | -57.3% | 3,500 | -35.2% | 0.04% | -60.8% |
| Q1 2021 | $117,000 | +42.7% | 5,400 | 0.0% | 0.10% | +31.1% |
| Q4 2020 | $82,000 | – | 5,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |